Article Information
History
- January 9, 2021.
Article Versions
- Version 1 (January 8, 2021 - 04:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Edoardo Gaude1,*,
- Barbara Nogueira1,
- Sheila Graham2,
- Sarah Smith2,
- Lisa Shaw3,
- Sara Graziadio4,
- Gonzalo Ladreda Mochales1,
- Marcos Ladreda Mochales1,
- Philip Sloan2,
- Joshua D. Bernstock5,
- Shashank Shekhar6,
- Toby I. Gropen7 and
- Christopher I. Price3
- 1Pockit Diagnostics Ltd, Cambridge, United Kingdom
- 2CEPA Biobank, The Newcastle NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- 3Stroke Research Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
- 4Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- 5Harvard Medical School, Boston, Massachusetts, USA
- 6University of Mississippi Medical Center, Jackson, Mississippi, USA
- 7University of Alabama at Birmingham, Birmingham, Alabama, USA
- ↵*Corresponding author: Email: edoardo.gaude{at}pockitdx.co.uk
Posted January 09, 2021.
Combination of blood biomarkers and stroke scales improves identification of large vessel occlusions
